Has Jennifer Myers, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,027 in general payments to Jennifer Myers, MD across 201 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jennifer Myers, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jennifer Myers, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jennifer Myers, MD

Dermatology · Youngsville, LANPI 1902007123

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.7% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Sanofi at 25.8% of the total. 2025 is the largest year on record at $854, 2.1 times the $406 reported in 2019. That places this record below the midpoint for dermatology clinicians in LA, where the typical reported total is $5,293.

$4,027in general payments, 2019–2025

Across 201 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$1K
Johnson & Johnson$745
AbbVie$694
Novartis$296
Sun Pharmaceutical Industries Inc.$232
Pfizer$181
plus $841 from 14 others

What the payments were for

Food & beverage$3,77394%
Education$2546%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	41	$1,039
Johnson & Johnson	22	$745
AbbVie	57	$694
Novartis	16	$296
Sun Pharmaceutical Industries Inc.	11	$232
Pfizer	11	$181
Lilly USA, LLC	7	$155
Galderma Laboratories, L.p.	9	$140
Amgen	5	$100
Arcutis Biotherapeutics, Inc.	4	$81
Incyte Corporation	4	$77
E.r. Squibb & Sons, L.L.C.	3	$67
EPI Health, LLC	3	$54
Revance Therapeutics, Inc.	1	$42
Almirall LLC	2	$37
Bristol Myers Squibb	1	$21
UCB, Inc.	1	$20
VYNE Pharmaceuticals Inc.	1	$17
LEO Pharma Inc.	1	$17
Journey Medical Corporation	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$130

How this compares

$4,027 in reported general payments places this provider in the 40th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$802,754

Medicare patients

1,404

Services billed

14,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab	19	$140,826
Dupixent SyringeDupilumab	11	$44,845
Fluorouracil	205	$13,463
Pimecrolimus	31	$9,565
Tacrolimus	47	$7,279
Ketoconazole	271	$4,461
Azelaic Acid	15	$3,061
Triamcinolone Acetonide	237	$2,735
Metronidazole	32	$1,668
CiclopiroxCiclopirox Olamine	46	$1,590
Hydroxychloroquine Sulfate	47	$1,514
ValacyclovirValacyclovir Hcl	52	$1,284
Doxepin Hcl	46	$1,259
Fluconazole	51	$1,125
Doxycycline Hyclate	85	$1,084

Paid to pharmacies, not to this prescriber.

Other dermatology in Youngsville

Katherine HolcombMetairie$411K
William ClaiborneNew Orleans$374K
Blair BuddenLafayette$329K
Erin BohNew Orleans$277K
Mara HaseltineNew Orleans$276K
Sarah HaydelHouma$265K
Frankie RholdonLafayette$227K
William MassengalePrairieville$225K
Julie MermilliodNew Orleans$222K
Robert KoppelMetairie$212K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →